The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

Amgen (NASDAQ:AMGN – Get Free Report) is expected to be issuing its quarterly earnings data after the market closes on ...

Equities research analysts at William Blair reduced their FY2024 earnings per share estimates for shares of Amgen in a ...

Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Disease-modifying anti-rheumatic drugs (DMARDs) primarily are used to treat rheumatoid arthritis ... to compare it to Otezla was completed in ...

As Dix points out, pharma reluctantly developed antibodies to treat severe inflammatory diseases such as rheumatoid arthritis because ... the psoriasis pill Otezla (apremilast).

Its key drugs include Humira for treating rheumatoid arthritis, psoriasis ... In the U.S., Amgen recently launched Otezla for treating plaque psoriasis in children ages 6 and older.

Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Disease-modifying anti-rheumatic drugs (DMARDs) primarily are used to treat rheumatoid arthritis. They're sometimes ... A phase 3 trial to compare it to ...